BUSINESS

• Japan’s Top 3 Drug Makers Join Forces on Biomarker Research
  May 24, 2016

• Repatha Shows Safety, Efficacy in Japanese Patients Regardless of Glycemic Status: Subanalysis Data
  May 24, 2016

• Ozawa to Step Down as J-TEC CEO, Fujifilm’s Hiruma to Take Over
  May 23, 2016

• Jiangsu Hengrui Medicine Eyes Launch of 2-3 Generics in Japan Every Year: CEO
  May 23, 2016

• Generic Makers Enjoy Revenue Rises as Govt Tailwinds Continue: Jiho Tally
  May 23, 2016

• Chugai, Osaka Univ. Clinch 10 Billion Yen Immunology Pact
  May 20, 2016

• Ono Ties Up with Univ. of Tokyo Venture for Antibody Drug
  May 19, 2016

• Suzuken Outstrips Medipal in Drug Wholesaling Biz on Hep C Boom: Jiho Tally
  May 19, 2016

• Takecab Most Heavily Pitched Drug for 3 Consecutive Months: Anterio
  May 18, 2016

• Harvoni Tops Japan Yearly Sales Ranking Only 7 Months after Launch: IMS
  May 18, 2016

• ASKA Dissolves Generic JV with Actavis
  May 17, 2016

• Medipal to Set Up Subsidiary for Specialty Drugs
  May 17, 2016

• Lilly, Kanazawa Medical Univ. Ink Research Deal on Diffuse-Type Gastric Cancer
  May 17, 2016

• Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
  May 17, 2016

• Chugai’s CellCept, Generic Versions Approved for Lupus Nephritis
  May 17, 2016

• Nippon Kayaku Faces Damage Suit over Elplat Patent
  May 17, 2016

• Santen Anticipates Continued Growth in Sales of Ikervis in Europe; 30% Overseas Sales Ratio an “Achievable Target”
  May 17, 2016

• As Tagrisso Launch Nears, AZ Pushes Stringent Prerequisites for Facilities, Doctors to Ensure Safety
  May 17, 2016

• Towa to Mull Over Distribution Dealing with Wholesalers
  May 17, 2016

• Eisai Aims for 10% Rise in Japan Pharma Sales with Patented Products: CEO
  May 16, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 459
• 460
• 461
• 462
• 463
• 464
• 465
• 466
• 467
• …
• Next ›
• 最終 »